Company / Operating Cash Flow per Share
INOVIO PHARMACEUTICALS, INC. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.88
FY2025
5-year range
-$10.23 / -$0.52
FY2021-FY2025
Trend
+47.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-10.23 in FY2023 to $-0.17 in FY2017.
Based on SEC 10-K filings.
-2.88 in FY2025.
Improved from $-10.23 to $-2.88 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 47.2% year-over-year.
- Peak operating cash flow per share was recorded in FY2017.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.88 | +47.2% |
| FY2024 | -$5.46 | +46.7% |
| FY2023 | -$10.23 | -1149.2% |
| FY2022 | -$0.82 | -56.3% |
| FY2021 | -$0.52 | +27.8% |
| FY2020 | -$0.73 | -11.6% |
| FY2019 | -$0.65 | +6.1% |
| FY2018 | -$0.69 | -312.2% |
| FY2017 | -$0.17 | +59.3% |
| FY2016 | -$0.41 | -63.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026